°C for 2 min, 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60 °C for 10 min. All reactions were run in duplicate and average threshold cycle was calculated. All reactions were run in duplicates using 7500 Real-Time PCR System. The resulting Cq values were determined using fixed threshold settings 0.2.
Absolute quantification of qPCR data
As there is still no reliable reference control for circulating miRNAs and U6RNA and 5S
rRNA are degraded in serum, we performed absolute quantification to determine the copy number of each miRNA per 1ng of total miRNA/RNA isolated. Absolute quantification requires standard samples that are used to plot a curve of cycle threshold (Ct) vs copy number. For each assay, calibration curve was prepared by ten-fold serial dilution of synthetic single-strand miRNA (hsa-miR-222, hsa-miR-744, hsa-miR-130a, hsa-miR-34a, hsa-let-7d and hsa-let-7e, all IDT, Coralville, Iowa, USA) from 0,01 fM/L to 10 4 fM/L, and the levels of the synthetic miRNAs were assessed by qRT-PCR assay as described (Supplementary Information (SI), Figure S1 ).
1

Assay precision of hydrolysis probe-based qPCR assay
Repeatability of miRNA/RNA extraction and analytical repeatability of the hydrolysis probebased qPCR assay was performed on pooled serum from 20 HD using 10 TaqMan miRNA specific assays (hsa-miR-29a-002112, hsa-miR-21-000397, hsa-miR-130a-000454, hsa-miR-19b-000396, hsamiR-16-000391, hsa-miR-34a-000426, hsa-let-7d-002283, hsa-let-7e-002406, hsa-miR-222-002276
and hsa-miR-744-002324) as described elsewhere (Supplementary Data, Figure S2 ).
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Interphase fluorescence in situ hybridization analysis (I-FISH)
The following aberrations were studied: gain 1q21, deletion 13q14, deletion 17p13 and translocation t(4;14). Hyperdiploidy status was determined by commercial probes mapping to chromosome 5 (LSI D5S23/D5S721), 9 (CEP9) and 15 (CEP15) (Abbott Molecular, Des Plaines, IL, USA).
Statistical analyses
Standard descriptive statistics were applied in the analysis; median supplemented by min-max or interquartile range for continuous variables and absolute and relative frequencies for categorical variables. Statistical significance of differences in continuous variables among groups of patients was analyzed using nonparametric Kruskal-Wallis or Mann-Whitney U test; Wilcoxon paired test was used for the analysis of paired data. For discrete variables, chi-square test or Fisher's exact test was used.
For the robust analysis of continuous parameters relationship, the Spearman correlation coefficient was adopted, Pearson correlation was adopted for the linearly dependent and normally distributed variables. Survival and progression rates were estimated using the Kaplan-Meier method. The overall survival (OS) and time-to-progression (TTP) were determined according to International Myeloma Working Group guidelines. 2 Differences in survival among subgroups of patients were compared using the log-rank test. Time-dependent receiver operating characteristic (ROC) was used for the identification of sensitivity, specificity and cut-off value of continuous variables for survival of patients in given time points. Cox proportional hazards models were used to assess the association of 
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